Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active Surveillance High-grade neuroendocrine carcinoma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback